Biotech company 10x Genomics (NASDAQ:TXG) will be reporting earnings tomorrow after market hours. Here’s what to look for.

In a stark reflection of the challenges facing the biotech sector, 10X Genomics Inc (NASDAQ:TXG) stock has tumbled to a 52-week low, touching down at $11.89. According to InvestingPro data, technical ...

BioSkryb Genomics, a Durham company focused on single-cell and ultra-low input multiomics, has introduced a new service called ResolveSEQ MRD, which allows more detailed classification and ...

Genomics company 10x and Harvard University have agreed to resolve a patent lawsuit against 10x's rival Vizgen four days into ...

CircleDNA powers blockchain-based identity verification with Humanity Protocol, valued at US $1.1bn after latest fundraisePrenetics invests $1.5M ...

Northwestern Medicine scientists have discovered new details about how the human genome produces instructions for creating ...

International collaboration in genomic research is gaining momentum in African countries and is often supported by external ...

Technological advances have reduced genome sequencing costs to $600, boosting growth in the genomics sector. The genetic testing market is forecast to hit $91.3 billion by 2034, enhancing disease ...

Landmark single-cell dataset of one billion cells will be used to train new AI models to advance understanding of cellular ...

A team of investigators from Dana-Farber Cancer Institute, The Broad Institute of MIT and Harvard, Google, and Columbia ...

Patrick Tan to receive Genome Valley Excellence Award at BioAsia for pioneering work in precision medicine and cancer ...

The 15th African Society of Human Genetics (AfSHG) and the inaugural Uganda Society of Human Genetics and Bioinformatics ...